We put together this list of highlights from 2021! These are some of the people, the work, and the campaigns that made this HER’s best year yet! We are making Hyperemesis Gravidarum (HG) progress!
The HER Foundation is thankful for our business partners who support our mission.
HER Board members, Marlena Fejzo, PhD, and Patrick Mullen, MD, are running the first study of GDF15 in HG patients in the United States.
We created this tool to help guide HG patients through the steps of self advocacy.
Hyperemesis Gravidarum (HG) is a risk factor for premature birth. On Prematurity Awareness Day, meet Crew and Tru.
In HER Words: Thank you for sharing your Hyperemesis Gravidarum (HG) journey. I had baby fever. I wanted a baby so bad it hurt. I was jealous of others who were…
Meet Kathryn Romine at 5 PM/PST on Sunday, October 24th, where she will share her HG journey with Kimber and explain why she is part of the HER Ambassador Council.…
Marlena Fejzo, PhD, HER Board Member and Research Advisor, presents at the American Society of Human Genetics Annual Meeting on the genetics of Hyperemesis Gravidarum (HG).
The Hyperemesis Education and Research Foundation’s mission is to provide Hyperemesis Gravidarum (HG) support, advocacy, education, and research to improve treatment and outcomes.
Dozens of mothers bravely raised their voices about the obstacles that prohibited them from being healthy, productive employees during their pregnancies, including insufficient job security and a lack of compassion from employers. We compiled their responses to make a succinct list employers can refer to when attempting to support employees with HG or other high risk pregnancy complications.
